ClinicalTrials.gov
ClinicalTrials.gov Menu

Lighthouse Project on Dementia, Ulm, Germany (ULTDEM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00693888
Recruitment Status : Unknown
Verified March 2009 by University of Ulm.
Recruitment status was:  Recruiting
First Posted : June 9, 2008
Last Update Posted : August 17, 2010
Sponsor:
Collaborators:
Federal Ministry of Health, Germany
Geriatric Center Ulm
Robert Bosch Medical Center
Information provided by:
University of Ulm

Brief Summary:

The Geriatric Center Ulm scientifically supported a three-year pilot study (ProjektDEMENZ Ulm), in which numerous findings on the system of care regarding people suffering from dementia and their relatives were determined.

One of the most important conclusions is the significant lack of information on the well-functioning network of the care system in Ulm. The full potential of the network is not being exploited.

The situation in the Alb-Donau-Kreis - the area surrounding Ulm - is very similar.

The investigators' aim is to improve the utilization of the system of care for those suffering from dementia in Ulm/Alb-Donau-Kreis by using a newly designed advisory approach (Lighthouse Project on Dementia, Ulm, ULTDEM study).

The purpose of the study is to prove the effectiveness of this procedure by using a prospective, open, randomized, controlled, interventional study.

After the randomization, the interventional group is given comprehensive, individual advice about available treatment possibilities for people suffering from dementia.

In addition, they have the opportunity to re-evaluate their present diagnostic procedure.

The participants of the control group receive the standard treatment. Inclusion criterion is the application of a care level ( level 0 or 1). Recruitment will take one year. A final assessment will be taken every six months.


Condition or disease Intervention/treatment Phase
Dementia Behavioral: advice (e.g. medical and social aspects, care, support at home, residential advice, legal aspects, demonstration of help and support for the relatives) Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Lighthouse Project on Dementia, Ulm, Germany - Improvement of Advice and Diagnostics for People Suffering From Dementia After the Classification of Their Level of Care (ULTDEM Study).
Study Start Date : June 2008
Estimated Primary Completion Date : February 2010
Estimated Study Completion Date : September 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dementia

Arm Intervention/treatment
Experimental: interventional group
individual comprehensive primary advice (e.g. medical and social aspects, care, support at home, residential advice, legal aspects, demonstration of help and support for the relatives)
Behavioral: advice (e.g. medical and social aspects, care, support at home, residential advice, legal aspects, demonstration of help and support for the relatives)
initial comprehensive assessment, stratified (city, suburbs) randomization into two groups: interventional group: individual comprehensive primary advice (medical and social aspects, care, support at home, residential advice, legal aspects, demonstration of help and support for the relatives), control group: standard support, observation over a period of 6 months, possibility of completing the diagnostic after final assessment

No Intervention: Control group
only informative flyer, no further advice in any direction



Primary Outcome Measures :
  1. Quality of life [ Time Frame: six months ]

Secondary Outcome Measures :
  1. health economical effects, progress of disease, level of evidence based on diagnosis, institutionalization, hospitalization, using support possibilities, use of drugs [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • dementia (MMSE < 24)
  • signing up for classification of care level (0 or 1)
  • community dwelling elderly (older than 60 years)
  • member of certain health insurance provider (AOK, Barmer, DAK)
  • residents of Ulm / Alb-Donau-Kreis

Exclusion Criteria:

  • result from the inclusion criteria
  • cancer
  • consuming disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00693888


Contacts
Contact: Albert Lukas, M.D. 1149-7311-87196 albert.lukas@bethesda-ulm.de
Contact: Thorsten Nikolaus, M.D., professor 1149-7311-87185 thorsten.nikolaus@bethesda-ulm.de

Locations
Germany
Geriatric Center Ulm (GZU), Bethesda Geriatrische Klinik Ulm Recruiting
Ulm, Baden-Württemberg, Germany, 89073
Contact: Albert Lukas, M.D.    1149-731-187196    albert.lukas@bethesda-ulm.de   
Contact: Thorsten Nikolaus, M.D., professor    1149-7311-87185    thorsten.nikolaus@bethesda-ulm.de   
Principal Investigator: Thorsten Nikolaus, M.D., professor         
Sponsors and Collaborators
University of Ulm
Federal Ministry of Health, Germany
Geriatric Center Ulm
Robert Bosch Medical Center
Investigators
Principal Investigator: Thorsten Nikolaus, M.D., professor Geriatric Center Ulm / Alb-Donau (GZU)

Responsible Party: Thorsten Nikolaus, M.D. professor, Geriatric Center Ulm (GZU)
ClinicalTrials.gov Identifier: NCT00693888     History of Changes
Other Study ID Numbers: LTDemenz-44-052
First Posted: June 9, 2008    Key Record Dates
Last Update Posted: August 17, 2010
Last Verified: March 2009

Keywords provided by University of Ulm:
dementia
system of care
level of care
interventional study
evaluation
dementia diagnostic
Evaluation of the care study

Additional relevant MeSH terms:
Dementia
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders
Tauopathies
Neurodegenerative Diseases